EUR 0.85
(2.41%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.43 Thousand EUR | -91.37% |
2022 | 132.49 Thousand EUR | -36.9% |
2021 | 209.98 Thousand EUR | 13.83% |
2020 | 184.46 Thousand EUR | 8.68% |
2019 | 169.73 Thousand EUR | -3.32% |
2018 | 175.56 Thousand EUR | 2556.71% |
2017 | 6608.48 EUR | 11.06% |
2016 | 5950.32 EUR | 8.51% |
2015 | 5483.79 EUR | -99.91% |
2014 | 6.16 Million EUR | 164.53% |
2013 | 2.32 Million EUR | 43.66% |
2012 | 1.62 Million EUR | 401.63% |
2011 | 323.14 Thousand EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 5.67 Million EUR | 0.0% |
2023 Q2 | 6.03 Million EUR | 0.0% |
2023 FY | 11.43 Million EUR | 8533.66% |
2023 Q4 | 5.4 Million EUR | 0.0% |
2022 Q4 | 20.07 Thousand EUR | 0.0% |
2022 FY | 132.49 Thousand EUR | -36.9% |
2022 Q2 | 112.41 Thousand EUR | 0.0% |
2021 FY | 209.98 Thousand EUR | 13.83% |
2021 Q4 | 114.58 Thousand EUR | 0.0% |
2021 Q2 | 95.4 Thousand EUR | 0.0% |
2020 Q2 | 89.45 Thousand EUR | 0.0% |
2020 FY | 184.46 Thousand EUR | 8.68% |
2020 Q4 | 95 Thousand EUR | 0.0% |
2019 Q4 | 2979.28 EUR | 0.0% |
2019 Q2 | 3043.82 EUR | 0.0% |
2019 FY | 169.73 Thousand EUR | -3.32% |
2018 Q2 | 619 Thousand EUR | 0.0% |
2018 Q4 | 7.51 Million EUR | 0.0% |
2018 FY | 175.56 Thousand EUR | 2556.71% |
2017 Q4 | 3458.91 EUR | 0.0% |
2017 FY | 6608.48 EUR | 11.06% |
2017 Q2 | 3149.56 EUR | 0.0% |
2016 FY | 5950.32 EUR | 8.51% |
2016 Q2 | 2908.91 EUR | 0.0% |
2016 Q4 | 3041.41 EUR | 0.0% |
2015 FY | 5483.79 EUR | -99.91% |
2015 Q2 | 2579.32 EUR | 0.0% |
2015 Q4 | 2904.47 EUR | 0.0% |
2014 Q1 | 1.06 Million EUR | 0.0% |
2014 Q2 | 1789.48 EUR | -99.83% |
2014 Q4 | 2197.29 EUR | -99.79% |
2014 FY | 6.16 Million EUR | 164.53% |
2014 Q3 | 1.06 Million EUR | 59602.8% |
2013 Q3 | 582.18 Thousand EUR | 0.0% |
2013 Q1 | 582.18 Thousand EUR | 0.0% |
2013 Q4 | 1.06 Million EUR | 83.51% |
2013 FY | 2.32 Million EUR | 43.66% |
2013 Q2 | 582.18 Thousand EUR | 0.0% |
2012 FY | 1.62 Million EUR | 401.63% |
2012 Q2 | 405.25 Thousand EUR | 0.0% |
2012 Q4 | 582.18 Thousand EUR | 43.66% |
2012 Q1 | 405.25 Thousand EUR | 0.0% |
2012 Q3 | 405.25 Thousand EUR | 0.0% |
2011 Q2 | 80.78 Thousand EUR | 0.0% |
2011 FY | 323.14 Thousand EUR | 0.0% |
2011 Q3 | 80.78 Thousand EUR | 0.0% |
2011 Q1 | 80.78 Thousand EUR | 0.0% |
2011 Q4 | 405.25 Thousand EUR | 401.63% |
2010 Q4 | 80.78 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | 99.904% |
Carmat SA | 21.54 Million EUR | 99.947% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | 99.937% |
Euromedis Groupe | 17.6 Million EUR | 99.935% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 99.976% |
Ikonisys S.A. | 2.44 Million EUR | 99.533% |
Implanet S.A. | 9.29 Million EUR | 99.877% |
Median Technologies SA | 46.34 Million EUR | 99.975% |
SpineGuard SA | 7.35 Million EUR | 99.844% |
Theraclion SA | -1.08 Million EUR | 101.059% |
Euroapi S.A. | 398.9 Million EUR | 99.997% |
Guerbet SA | 550.79 Million EUR | 99.998% |
Ion Beam Applications SA | 128.02 Million EUR | 99.991% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 100.0% |
Sequana Medical NV | 30.03 Million EUR | 99.962% |